Your labs come back, hematocrit is flagged, and the first instinct is to panic or to want to quit. I hear that a lot, and I get it. A high number on a lab report feels like something is wrong.
Here's the short version up front. A rise in hematocrit on TRT is expected, common, and manageable. It does not mean your treatment broke. It means testosterone is doing one of the things it is supposed to do: telling your body to make more red blood cells.
I cover all of this in under 6 minutes if you'd rather watch.
What hematocrit is and why TRT raises it
Hematocrit is the share of your blood made up of red blood cells. Those cells carry oxygen. Testosterone tells your body to make more of them, so a rise is an expected effect of therapy, not a random glitch.
It's one of the main numbers we track on TRT labs. When it moves, that often means the hormone is working. Your provider still watches the trend, because the goal is to keep you feeling well and to understand the whole picture, not to chase a single number in isolation.
Expected, common, and manageable
Managing it is not dramatic. It means regular labs and a provider watching how your number moves over time, along with how you feel and the rest of your panel. If it climbs, you deal with it on purpose, one change at a time. You don't throw out the plan in a panic.
What the biggest TRT safety trial found
The biggest safety trial on this is TRAVERSE, published in the New England Journal of Medicine in 2023. It enrolled 5,246 men, ages 45 to 80, who already had heart disease or a high risk of it. They were followed for a mean of 33 months.
Major heart events, meaning cardiovascular death, nonfatal heart attack, or nonfatal stroke, happened in 7.0% of men on testosterone and 7.3% of men on placebo. Testosterone was no worse than placebo for that main safety question.
A later look at men in that trial who started out with anemia found that change in hematocrit was not associated with major heart events or venous clots. That was not the main TRAVERSE result, and it applied to that group of men.
Why 7.0 versus 7.3 isn't a real difference
Three tenths of a point is too small to matter in real life. In a study this size, those numbers are basically the same. That's why the trial concluded testosterone did not raise overall heart risk compared with placebo.
Is 54% hematocrit dangerous?
54% is a guideline safety margin. It's the point where your provider takes a closer look, not a proven cliff where risk suddenly jumps.
The Endocrine Society's 2018 guideline put it plainly: "The hematocrit level at which the risk of neuro-occlusive or cardiovascular events increases is not known."
A 2022 review of the cutoffs used in guidelines said they "appear to be arbitrarily chosen."
That does not mean the number gets ignored. It means 54% is a cue to evaluate, not a verdict.
One 2022 observational study looked at men on testosterone whose hematocrit reached 52% or higher. After accounting for things like age and sleep apnea, those men still had more heart or clot events in the first year than men whose hematocrit stayed lower. That's a link, not proof of cause, and it isn't a randomized trial like TRAVERSE. It's one more reason your provider looks at the whole person, not just the number.
Got a number you want explained? Take the hormone quiz and bring it to your visit. Start the quiz.
Erythrocytosis is not polycythemia vera
This distinction matters, and it gets blurred a lot.
TRT raises red blood cells only. That's called erythrocytosis. Polycythemia vera is a real blood disease, where red cells, white cells, and platelets can all go up, and that disease can cause clots.
As Dr. Neal Rouzier put it on The Delgado Protocol, "It causes erythrocytosis, which is only an increase in red blood cells, which is harmless."
That's his wording, and it's why the two conditions should not be treated as the same thing. Your provider still reviews your labs. If something besides red cells is climbing, that's a different conversation.
What people at high altitude teach us
In La Rinconada, Peru, the highest city in the world, researchers studied 1,594 residents. The median hematocrit was 60%. The trigger there is thin air, not testosterone. The result is similar in one way: the body makes more red blood cells. The mechanism is not the same, and these are not the same people as a man on TRT in Missouri. Still, it shows that a naturally higher hematocrit can be part of how a body adapts.
Doctors don't routinely take blood out of people who live at altitude, or of people with COPD whose red cells rise because they need the extra oxygen those cells carry. Rouzier's point was the same for testosterone: "We should not phlebotomize people that have high RBC levels because of taking testosterone."
Why dumping blood isn't the fix
Taking blood out can lower the number for a while, but it can also strip iron. The number often climbs back, because testosterone is still telling the body to make red cells. That's why the more useful move is usually to adjust the input, not to keep draining the output, and to do it with your provider.
If your HCT climbs: one change at a time
Don't panic, and don't change everything at once. If you stop therapy and also change how it's set up and change a half dozen other things on the same day, you would never know what actually helped.
Make one change, then recheck labs and see what moved.
What a provider might look at includes how therapy is set up, whether sleep apnea is in the picture, and whether a single lab draw was thrown off by dehydration. Being dried out can nudge a reading up. None of that is a do-it-yourself protocol. It's a conversation with the person watching your trend.
Here's your next step
Questions about your labs? Start here. We'll go through your numbers with you and figure out the next step.
You can also see how we run labs on our bloodwork page, and read more about treatment on our testosterone therapy page.
If you prefer short videos, I also made four short clips on this same topic: what a rise in hematocrit means, what 54% is, what altitude teaches us, and why not to panic.
Frequently asked questions
Is high hematocrit on TRT dangerous?
A rise is expected. In TRAVERSE, major heart events were 7.0% on testosterone and 7.3% on placebo. A later look at men in that trial who started with anemia found that change in hematocrit was not associated with major heart events or venous clots. Your provider manages it with regular labs.
What hematocrit is too high on TRT?
Guidelines use 54% as a point to look closer. It's a safety margin, not a proven danger line.
Is dumping blood the fix for high hematocrit on TRT?
No. It can strip iron, and the number often climbs back. Work with your provider on the input, one change at a time.
Does TRT cause polycythemia?
TRT causes erythrocytosis, more red blood cells only. Polycythemia vera is a different disease.
Can drinking water lower my hematocrit?
Being dehydrated can push a single lab reading up, so a well hydrated draw gives a truer number. Water isn't a treatment.
How often should HCT be checked on TRT?
Your provider sets the schedule with your regular labs.
Sources
- Lincoff AM et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med 2023, 389:107 to 117.
- Pencina KM et al. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open 2023, 6(10):e2340030.
- Hackett GI. Long Term Cardiovascular Safety of Testosterone Therapy: A Review of the TRAVERSE Study. World J Mens Health 2025, 43:282 to 290.
- Bhasin S et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018, 103:1715 to 1744.
- White J, Petrella F, Ory J. Testosterone therapy and secondary erythrocytosis. Int J Impot Res 2022, 34:693 to 697.
- Ory J et al. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. J Urol 2022, 207:1295 to 1301.
- Hancco I et al. Excessive Erythrocytosis and Chronic Mountain Sickness in Dwellers of the Highest City in the World. Front Physiol 2020, 11:773.
- Lundy SD, Parekh NV, Shoskes DA. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy. J Sex Med 2020, 17:1297 to 1303.
- Dr. Neal Rouzier on The Delgado Protocol (quotes verified word for word against the October 23, 2026 transcript).
Educational only. Talk to a licensed provider about your own labs.
Reviewed by Summit Rejuvenation's licensed medical team.

